BioAsia 2026, the 23rd edition of Asia’s premier life sciences and health-tech forum, will be held over two days in Hyderabad from February 17.

With ‘TechBio unleashed: AI, automation and the biology revolution’ as its theme, it will reflects the pivotal convergence of biology, data and deep technology that is reshaping drug discovery, diagnostics, manufacturing of therapies and healthcare delivery globally.

TechBio is transforming how diseases are understood, how therapies are designed, and how care is delivered thus making healthcare more predictive, personalised and accessible while strengthening a resilient and inclusive global health system, the organisers said after Industries and IT Minister D. Sridhar Babu unveiled the poster in the presence of officials.

“As Telangana embarks on its journey to become a $3 trillion economy by 2047, Life Sciences sector will play a critical role in shaping the growth of the State. Marquee event like BioAsia showcases Telangana’s leadership in life sciences and healthcare innovation and acts as a pivotal platform to foster new partnerships and explore opportunities for growth in this segment,” Mr. Sridhar Babu said.

Special Chief Secretary-Industries and IT Sanjay Kumar said BioAsia 2026 will provide a powerful platform for collaboration among startups, researchers, industry leaders, and policymakers.

The event will connect innovators with investors, act as a bridge between laboratory breakthroughs and market adoption and provide a forum for policymakers to co-create regulatory frameworks that encourage innovation while safeguarding patient safety and public interest, the organisers said.

Telangana Life Sciences Foundation CEO Shakthi Nagappan said “TechBio is redefining the very foundations of healthcare and life sciences. As biology converges with AI, automation and data, we see unprecedented opportunities for innovation, investment and impact.”


Leave a Reply

Your email address will not be published. Required fields are marked *